FDA demands larger trials, stricter safety proof before vaccines approved — citing internal link between COVID‑19 shots and ...
The top vaccine chief at the Food and Drug Administration sent out a memo saying the FDA will seek a stricter review and ...
As the FDA's Commissioner's National Priority Voucher (CNPV) program has picked up steam, with 15 companies now having ...
The FDA has delayed a decision on Ascendis Pharma’s dwarfism drug candidate TransCon CNP, pushing back the deadline by three ...
The FDA has launched a free mobile app version of its Drugs@FDA online database that offers consumers information on agency-approved drugs. The new app, called Drugs@FDA Express, is free and currently ...
FDA is reviewing a new diabetes pill and oral Ozempic alternatives, raising questions about safety, access, pricing ...
ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology ...
The Trump administration is casting more doubt on the safety of vaccines, with an internal memo from the Food and Drug ...
Vaccine experts said the memo was irresponsible and omits key details about how officials arrived at the conclusion.
If your summer skincare looks more like dessert than SPF, the Food and Drug Administration (FDA) has a message: Put down the whipped cream canister—especially if it’s sunscreen. On Monday, the agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback